Use of the Gore Tigris Vascular Stent in Advanced Femoropopliteal Peripheral Arterial Disease

The Tigris stent used alone or in combination with a Viabahn stent for femoropopliteal TASC B-D lesions demonstrated acceptable 12-month primary patency with a low reintervention rate.